Heamclas FCM stands for Ferric Carboxymaltose, a novel iron replacement product used primarily to treat iron deficiency anemia. Unlike traditional oral iron supplements, Heamclas FCM is administered intravenously, offering a rapid and efficient method to replenish iron levels in the body. Its unique formulation ensures high bioavailability and minimizes common side effects associated with oral iron therapies.